What is NDC 59746-466?

59746-466 is the product NDC for olmesartan medoxomil, Olmesartan medoxomil 40 mg/1 tablet, film coated, listed with the FDA by Jubilant Cadista Pharmacuticals Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.

Jubilant Cadista Pharmacuticals Inc., NDC labeler code 59746. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for olmesartan medoxomil?

122 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

olmesartan medoxomil NDC 59746-466

NDC codes

FDA NDC Directory

Product NDC (as listed)59746-466Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59746-0466Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59746-466-01	5974604660159746046601	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-466-01)Marketed from Apr 24, 2017
59746-466-10	5974604661059746046610	1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-466-10)Marketed from Apr 24, 2017
59746-466-30	5974604663059746046630	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-466-30)Marketed from Apr 24, 2017
59746-466-32	5974604663259746046632	3 BLISTER PACK in 1 CARTON (59746-466-32) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Apr 24, 2017
59746-466-90	5974604669059746046690	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59746-466-90)Marketed from Apr 24, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): olmesartan medoxomil
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Jubilant Cadista Pharmacuticals Inc.NDC labeler code 59746
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205482
Marketing start: Apr 1, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 59746-466_09a95078-de95-4c58-a910-4cd3b6f04810SPL ID 09a95078-de95-4c58-a910-4cd3b6f04810SPL set ID d5658d8a-f8e9-454d-89a9-34884e753001RxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0359746463328, 0359746466305, 0359746466329, 0359746465322, 0359746465308, 0359746463304
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459746046601 followed by a unit qualifier and the quantity

Package 59746-0466-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 23, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, d…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59746-466

What is NDC 59746-466?: 59746-466 is the product NDC for olmesartan medoxomil, Olmesartan medoxomil 40 mg/1 tablet, film coated, listed with the FDA by Jubilant Cadista Pharmacuticals Inc.. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: olmesartan medoxomil.
What is the active ingredient?: Olmesartan medoxomil.
Who is the labeler?: Jubilant Cadista Pharmacuticals Inc., NDC labeler code 59746. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for olmesartan medoxomil?: 122 other product NDCs are listed under this name. See all olmesartan medoxomil NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other olmesartan medoxomil NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	NorthStar RxLLC	72603-950	72603-0950-0172603-0950-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	NorthStar RxLLC	72603-951	72603-0951-0172603-0951-02
Olmesartan medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	NorthStar RxLLC	72603-952	72603-0952-0172603-0952-02
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0848	72303-0848-0172303-0848-02
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0849	72303-0849-0172303-0849-02
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	HEC Pharm USA Inc.	72303-0850	72303-0850-0172303-0850-02
Olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4598	70518-4598-00
Olmesartan Medoxomil	Olmesartan medoxomil 40 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-011	60290-0011-0160290-0011-0260290-0011-03
Olmesartan Medoxomil	Olmesartan medoxomil 5 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-009	60290-0009-0160290-0009-0260290-0009-03
Olmesartan Medoxomil	Olmesartan medoxomil 20 mg/1	TabletOral	Umedica Laboratories USA Inc.	60290-010	60290-0010-0160290-0010-0260290-0010-03

All 123 olmesartan medoxomil NDCs

Other NDCs under ANDA 205482

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205482
Product	Strength	Form · route	Labeler	Product NDC
olmesartan medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmacuticals Inc.	59746-463
olmesartan medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	Jubilant Cadista Pharmacuticals Inc.	59746-465